Resultados de la búsqueda 41-50 of 766 for ������������������������ ������������KaKaotalk:PC53���24������ ���������������

1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Jacksonville, Fla. The chimeric antigen receptor (CAR) T-cell therapy is a revolutionary cellular immunotherapy strategy that has transformed the treatment of B ...

2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Jacksonville, Fla. The chimeric antigen receptor (CAR) T-cell therapy is a revolutionary cellular immunotherapy strategy that has transformed the treatment of B ...

3. Procedimiento de Whipple - Médicos y departamentos - Mayo Clinic

   Accessed March 24, 2023. Reber HA. Surgical resection of lesions of the head of the pancreas. https://www.uptodate.com/contents/search. Accessed March 24, 2023.

4. Procedimiento de Whipple - Médicos y departamentos - Mayo Clinic

   Accessed March 24, 2023. Reber HA. Surgical resection of lesions of the head of the pancreas. https://www.uptodate.com/contents/search. Accessed March 24, 2023.

5. Hematología - Ensayos clínicos - Mayo Clinic

   The therapy, IC19/1563, uses some of the patients own immune cells, called T cells, to kill cancer. T cells fight infections and, in some cases, can also kill ...

6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   SC nivolumab in-home treatment may be safe, tolerable and/or effective when compared to in-clinic treatment and may reduce the burden of cancer and improve the ...

7. Hematología - Ensayos clínicos - Mayo Clinic

   The therapy, IC19/1563, uses some of the patients own immune cells, called T cells, to kill cancer. T cells fight infections and, in some cases, can also kill ...

8. Procedimiento de Whipple - Médicos y departamentos - Mayo Clinic

   Accessed March 24, 2023. Reber HA. Surgical resection of lesions of the head of the pancreas. https://www.uptodate.com/contents/search. Accessed March 24, 2023.

9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...

10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...